Allied Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALID research report →
Price Chart
About the company
Allied Corp. (ALID) specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands.
- CEO
- Michael Moses
- IPO
- 2019
- Employees
- 150
- HQ
- Kelowna, BC, CA
Get TickerSpark's AI analysis on ALID
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $57.75K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.80
- P/B
- -0.01
- EV/EBITDA
- -0.85
- Div Yield
- 0.00%
- Gross Margin
- -2027.53%
- Op Margin
- -14235.43%
- Net Margin
- -14807.58%
- ROE
- 261.44%
- ROIC
- 1003.32%
Latest fiscal year · YoY change
- Revenue
- $72.10K-56.5%
- Gross Profit
- $-1,461,767-2072.2%
- Op Income
- $-10,263,175
- Net Income
- $-10,675,671+36.4%
- EPS
- $-0.11+38.9%
- OCF Growth
- +54.3%
- FCF Growth
- +62.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.68
- RSI (14)
- 52
- Avg Volume
- 266
No earnings-call transcripts are available for ALID yet.
- Free Float
- 73.1%
- Shares Outstanding
- 115.50M
- Float Shares
- 84.43M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 23 | Robinson James George | buy | 40,000 |
| Apr 25, 23 | Robinson James George | buy | 40,000 |
| Sep 9, 19 | Bullock Paul James | other | 0 |
| Sep 9, 19 | Hughes Calum | other | 0 |
| Sep 9, 19 | Weinkauf David | other | 0 |
| Sep 9, 19 | Zelen Anthony | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ALID coverage
Recent articles, reports, and earnings notes.
No research on ALID yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALID report →Allied Corp Announces Signing of Supply Contracts of 85,000, 40,000 and 24,000 Kilograms for the 2022 Calendar Year
globenewswire.com · Oct 7
Allied Corp Announces Approval of Research and Plant Breeding License for Psychoactive and Non-Psychoactive Cannabis in Colombia
globenewswire.com · Sep 30
Allied Corp Provides Results of Recent Third Party Audit Confirming Production Costs and Optimization of Production
globenewswire.com · Sep 24
Allied Corp. Announces Approval of Second CBD Isolate Import Permit for Australia and Submits Application for the Import of Dried Cannabis
globenewswire.com · Sep 20
Allied Corp Provides Update Regarding Nevada Building and Option to Purchase Nevada State License
globenewswire.com · Sep 15
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process
globenewswire.com · Sep 10
Allied Corp. Initiates Additional Shipment of 200kgs of CBD Distillate From Colombia to Nevada, United States
globenewswire.com · Aug 25
Allied Corp. Signs Additional Supply Contracts for the Export of Cannabis Flower and CBD Isolate From Colombia to Australia
globenewswire.com · Aug 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.